Lesions on both the right and left atria can be created successfully on the beating heart with irrigated bipolar radiofrequency. The great majority of lesions with this device were transmural. This device should not be used on valvular tissue.

No abstract

Dr. Culbertson is a consultant to Abbott Medical Optics, Inc., and Optimedica Corp. Dr. Yoo is a consultant to Alcon Laboratories, Inc., and Abbott Medical Optics, Inc.. No other author has a financial or proprietary interest in any material or method mentioned.

This large series demonstrates that aggressive treatment of renal cell carcinoma with venous thrombus provides favorable outcomes. Our 5-year survival is among the highest of recent reviews, and our perioperative morbidity and mortality rates are comparable with those of other series. Tumors that require cardiovascular procedures are associated with increased complications when compared with radical nephrectomy and thrombectomy alone. Nevertheless, this aggressive treatment approach offers encouraging patient survival.

Purpose To report a single case of acquired sessile hemangioma of the conjunctiva which resolved after treatment with topical timolol. Methods Case report and literature review. Results A 77-year old African-American woman developed an acquired sessile hemangioma of the conjunctiva of the right eye. She was followed for primary open-angle glaucoma, and the lesion was monitored for 12 months without change. Topical timolol-dorzolamide was then added to her glaucoma medication regimen twice daily. On follow-up examination 6 months later, the lesion had completely resolved. Conclusion In this case report, an acquired sessile hemangioma of the conjunctiva resolved with topical timolol therapy.